WhichRecall
Class IIReported 2025-07-23

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC

Reason for Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).

Advertisement
Recall Number
D-0516-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-06-16
Reported
2025-07-23
Distribution
Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
Code Info
Lot # AD42648, Exp 02/28/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement